Monica Seles participates in a gMG awareness walk with members of the gMG community.
Monica Seles participates in a gMG awareness walk with members of the gMG community.
Monica Seles participates in a gMG awareness walk with members of the gMG community.

Teaming up for a new challenge

Tennis legend Monica Seles is rallying the gMG community and making every step count as the newest Voice of VYVGART.

Tennis Hall of Famer Monica Seles is no stranger to challenges. That’s clear from her impressive stats. But in 2022, she faced a new kind of challenge when she was diagnosed with anti-AChR antibody positive gMG. “I knew I had a fight in front of me,” she says, “but I was ready to face it full on.”

Adjusting to life with gMG hasn’t been easy. Symptoms could feel isolating. She couldn’t find many resources for people with gMG at the time. Starting VYVGART for intravenous (IV) infusion was a step in the right direction for symptom improvement, but there was one thing that Monica still wanted to do.

“I have learned that managing gMG isn't something I have to do alone,” she says. “Now, I’m using my platform to let others with gMG know that we’re in this together.”

“Managing gMG isn’t something I have to do alone.”

The power of persistence

Monica first started noticing symptoms in 2020. She had been teaching youth tennis clinics and needed more breaks than usual. “The fatigue made it hard to move to the ball,” she says. “Sometimes, I would see 2 tennis balls.”

She knew this was more than ordinary tiredness. “As an athlete, I’ve always been attuned to my body. And these symptoms were big changes.” But a clear diagnosis didn’t come right away. She visited several neurologists before she found one that recognized her symptoms and diagnosed her with gMG.

“If you’re not feeling how you think you should be feeling, you have to advocate for yourself,” says Monica. “For me, that meant not giving up until I had an answer. I found a neurologist who could be a partner in my treatment.”

Monica sits on a blanket in a park taking a photo of her dog. Monica sits on a blanket in a park taking a photo of her dog. Monica sits on a blanket in a park taking a photo of her dog.
Monica sits at a desk with a laptop and microphone recording a podcast interview. Monica sits at a desk with a laptop and microphone recording a podcast interview. Monica sits at a desk with a laptop and microphone recording a podcast interview.

Since starting VYVGART, Monica has noticed improvements in her daily abilities. Today, she enjoys hobbies like photography and supporting animal rescue organizations. As a Voice of VYVGART, she continues to raise awareness about gMG and VYVGART.

The road to VYVGART

In 2023, her doctor suggested adding VYVGART for IV infusion to her current treatment. At first, Monica felt hesitant. VYVGART for IV infusion was a new treatment at the time, and she only knew of one other person who was taking it. “When a new medicine comes out, you naturally feel a little nervous,” she says. “That's why I appreciated it when my neurologist gave me information and let me do my own research. Now I just wish I had started on VYVGART sooner.”

“My symptoms were taking away too much of my day-to-day life,” she says. “I didn’t know what to expect with VYVGART, but it felt worth it to try.” Monica decided to move forward with VYVGART later that year.

“My symptoms were a struggle for me every day.”

As part of that discussion, Monica's doctor explained to her that patients should not use VYVGART for IV infusion if they are allergic to any of its ingredients. This medicine may increase infection risk and cause serious allergic or infusion-related reactions. Most common side effects include respiratory and urinary tract infections and headache. See Important Safety Information below.

Today, people living with gMG have more ways to find community and support. Whether it’s a gMG support group or a mentorship program like My VYVGART Journey, Monica encourages people to connect and ask their questions about gMG and VYVGART. “If you’re not sure whether VYVGART is right for you, hearing about it firsthand can be valuable,” she says. “The more you know, the more confident you can feel in your next step.”

Monica smiles and chats with members of the gMG community while participating in an awareness walk. Monica smiles and chats with members of the gMG community while participating in an awareness walk. Monica smiles and chats with members of the gMG community while participating in an awareness walk.

Small wins with big impact

Not being able to play tennis was the biggest change in Monica’s life. But it’s the small wins that have surprised her the most since starting on VYVGART for IV infusion.

“I’ve had less weakness in my legs and less double vision. I can do more of the things that are important to me.” Things like walking with her friends or her dog, Astro. She’s picked up new hobbies, like photography and making jewelry. “These wins help motivate me to stay on VYVGART,” she says. “They’re the things that really help me.”

Join the challenge with Monica and see what treatment your way could look like*

GET STARTED

Giving back to the gMG community

From Monica’s first gMG symptoms to starting treatment with VYVGART, the gMG community has been an anchor. Early on, she joined gMG advocacy groups anonymously, not wanting to make a stir as a public figure. Now, she’s ready to rally the whole community.

“Challenges don’t define us. How we face them does.”

“The gMG community inspires me every day. Hearing firsthand experiences from other people going through this is important,” she says. “Each story reminds me how powerful it is when we share our experiences. That’s why I’m so excited to share mine.”

“I’ve learned challenges don’t define us,” she adds. “How we face them does.”

Monica Seles is a paid spokesperson taking VYVGART for IV infusion.
*Registration closes September 15, 2026.
AChR=acetylcholine receptor.

Read more from MY Way Magazine

GO BACK
VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) | VYVGART (efgartigimod alfa-fcab)
VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) | VYVGART (efgartigimod alfa-fcab)

Still have questions? Call 1-833-VYVGART (1-833-898-4278) to speak with an educator about gMG, how VYVGART works in the body, study data, cost and coverage, and more.

Do not take VYVGART if you are allergic to efgartigimod alfa or any of the ingredients in VYVGART. Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART or VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART or VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART or VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART or VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART or VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART or VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART or VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART or VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge

  • Allergic reactions (hypersensitivity reactions). VYVGART or VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART infusion or VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction with VYVGART or VYVGART HYTRULO:

    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • trouble breathing
    • low blood pressure
    • fainting

    An additional symptom of an allergic reaction with VYVGART HYTRULO can include hives.

  • Infusion or injection-related reactions. VYVGART can cause infusion-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART infusion or VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART or VYVGART HYTRULO include respiratory tract infection, headache, and urinary tract infection. An additional common side effect with VYVGART HYTRULO includes injection site reactions.

These are not all the possible side effects of VYVGART or VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines used to treat adults with generalized myasthenia gravis (gMG).

It is not known if VYVGART or VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO for subcutaneous injection and full Prescribing Information for VYVGART for IV infusion.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial. VYVGART is available as a single-dose injection for intravenous use containing 400 mg/20 mL of efgartigimod alfa-fcab per vial.

Do not take VYVGART if you are allergic to efgartigimod alfa or any of the ingredients in VYVGART. Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART or VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART or VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART or VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART or VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART or VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART or VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART or VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART or VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge

  • Allergic reactions (hypersensitivity reactions). VYVGART or VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART infusion or VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction with VYVGART or VYVGART HYTRULO:

    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • trouble breathing
    • low blood pressure
    • fainting

    An additional symptom of an allergic reaction with VYVGART HYTRULO can include hives.

  • Infusion or injection-related reactions. VYVGART can cause infusion-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART infusion or VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART or VYVGART HYTRULO include respiratory tract infection, headache, and urinary tract infection. An additional common side effect with VYVGART HYTRULO includes injection site reactions.

These are not all the possible side effects of VYVGART or VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines used to treat adults with generalized myasthenia gravis (gMG).

It is not known if VYVGART or VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO for subcutaneous injection and full Prescribing Information for VYVGART for IV infusion.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial. VYVGART is available as a single-dose injection for intravenous use containing 400 mg/20 mL of efgartigimod alfa-fcab per vial.

Questions? Call 1-833-VYVGART
(1-833-898-4278)

This site is intended for patients and caregivers.

Disclaimer | Privacy Policy | Contact Us |

Patient and Prescribing Information
VYVGART Hytrulo Patient Information VYVGART Hytrulo Prescribing Information VYVGART Hytrulo Prefilled Syringe Instructions for Use VYVGART for IV Infusion Prescribing Information

VYVGART and VYVGART Hytrulo are registered trademarks of argenx.

For U.S. audiences only.

©2026 argenx 

US-VYV-26-00029 V1 06/2026

argenx logo